FREMONT, Calif., June 9 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI - News) today announced that Mark McDade, Chief Executive Officer, and Andrew Guggenhime, Senior Vice President and Chief Financial Officer, will participate in several investor conferences in the coming weeks. The conferences include.
